I want to comment on a very common theme I see on

I want to comment on a very common theme I see on Cytodyn boards . Specifically the feeling of how can a drug we believe works go through a process like the trials when 1,000 people are dying every day from Covid in the US. Believe me I get frustrated by this process also sometimes .But there are many drugs going thru the same , what seems like a tedious process which will greatly improve people’s lives for heart disease and cancer, which each individually kill far more people per year than Covid. Together 1.2 million a year die from one of these disease. Covid is right behind these two at 223,000 as of today . I think what’s happening is many investors are seeing, for the first time perhaps in their investment lives, how difficult it is to get “ airtime” with the health care bureaucracies in Washington DC for many small biotech firms when a lot of that air is going towards large pharmas with established relationships with these organizations . Hence why a drug such as a Remdisivir , whose performance is, to be kind, underwhelming, gets approval and a Cytodyn continues on its current path without getting special attention from the FDA... If you look back at the Wainright downgrade of Cytodyn several months back, the comments made in the downgrade were around “ headwinds “ that might be facing Cytodyn. I am not sure many of us took those comments to heart because we believe in this drug. It was definitely words of wisdom that we are seeing more clearly now as we work thru the process to approval . My belief is we will persevere and eventually get approved because the science is truly consistent in what Leronlimab can do and the trial itself is moving along quickly . But, in my opinion , we will probably see one or two more big Pharma drugs getting some form of a blessing from the FDA beforehand..